Smith & Nephew (SNN) Stock Forecast, Price Target & Predictions
SNN Stock Forecast
Smith & Nephew (SNN) stock forecast, based on 20 Wall Street analysts, predicts a 12-month average price target of $27.00, with a high of $27.00 and a low of $27.00. This represents a 4.13% increase from the last price of $25.93.
SNN Stock Rating
Smith & Nephew stock's rating consensus is Hold, based on 20 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (35.00%), 12 Hold (60.00%), 1 Sell (5.00%), and 0 Strong Sell (0.00%).
Hold
SNN Price Target Upside V Benchmarks
Type | Name | Upside |
---|---|---|
Stock | Smith & Nephew | 4.13% |
Sector | Healthcare Stocks | 35.25% |
Industry | Medical Device Stocks | 21.20% |
Price Target Trends
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 1 |
Avg Price Target | - | - | $27.00 |
Last Closing Price | $25.93 | $25.93 | $25.93 |
Upside/Downside | - | - | 4.13% |
Ratings Trends
Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
---|---|---|---|---|---|---|
Apr, 25 | 1 | 2 | 2 | - | - | 5 |
Mar, 25 | 1 | 2 | 2 | - | - | 5 |
Feb, 25 | 1 | 2 | 2 | - | - | 5 |
Jan, 25 | 1 | 2 | 2 | - | - | 5 |
Dec, 24 | 1 | 2 | 2 | - | - | 5 |
Analyst Price Target Forecasts
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Nov 04, 2024 | Kyle Rose | Canaccord Genuity | $27.00 | $25.28 | 6.80% | 4.13% |
Analyst Rating Forecasts
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Mar 03, 2025 | Deutsche Bank | Hold | Hold | hold |
Nov 04, 2024 | Canaccord Genuity | Hold | Hold | hold |
Oct 14, 2024 | RBC Capital | Outperform | Outperform | hold |
Aug 02, 2024 | Barclays | Equal-Weight | Equal-Weight | hold |
Jul 24, 2024 | Deutsche Bank | Buy | initialise | |
Jun 05, 2024 | UBS | Neutral | Buy | upgrade |
May 22, 2024 | Liberum | Hold | downgrade | |
Oct 04, 2022 | Barclays | Overweight | Overweight | hold |
Aug 04, 2022 | Barclays | Overweight | Overweight | hold |
Apr 29, 2022 | UBS | Neutral | Neutral | hold |
Financial Forecast
EPS Forecast
Annual
Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
---|---|---|---|---|---|---|---|---|---|
Reported | $0.51 | $0.60 | $0.26 | $0.60 | - | - | - | - | - |
Avg Forecast | $1.26 | $1.65 | $1.55 | $1.64 | $1.66 | $1.94 | $2.16 | $2.33 | $2.57 |
High Forecast | $1.28 | $1.68 | $1.59 | $1.85 | $1.67 | $2.01 | $2.21 | $2.34 | $2.59 |
Low Forecast | $1.25 | $1.64 | $1.54 | $1.48 | $1.64 | $1.89 | $2.09 | $2.31 | $2.55 |
Surprise % | -59.52% | -63.64% | -83.23% | -63.41% | - | - | - | - | - |
Revenue Forecast
Annual
Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
---|---|---|---|---|---|---|---|---|---|
Reported | $4.56B | $5.21B | $5.21B | $5.55B | - | - | - | - | - |
Avg Forecast | $4.61B | $5.22B | $5.20B | $5.55B | $5.78B | $6.04B | $6.36B | $6.69B | $7.14B |
High Forecast | $4.67B | $5.28B | $5.29B | $5.57B | $5.78B | $6.06B | $6.37B | $6.72B | $7.17B |
Low Forecast | $4.58B | $5.19B | $5.17B | $5.51B | $5.73B | $6.03B | $6.35B | $6.64B | $7.09B |
Surprise % | -1.19% | -0.18% | 0.29% | 0.05% | - | - | - | - | - |
Net Income Forecast
Annual
Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
---|---|---|---|---|---|---|---|---|---|
Reported | $448.00M | $524.00M | $223.00M | $263.00M | - | - | - | - | - |
Avg Forecast | $894.21M | $983.63M | $1.08B | $1.19B | $724.19M | $846.78M | $944.73M | $1.02B | $1.12B |
High Forecast | $1.07B | $1.18B | $1.30B | $1.43B | $728.48M | $876.42M | $965.91M | $1.02B | $1.13B |
Low Forecast | $715.37M | $786.91M | $865.60M | $952.16M | $715.62M | $825.61M | $915.07M | $1.01B | $1.11B |
Surprise % | -49.90% | -46.73% | -79.39% | -77.90% | - | - | - | - | - |